杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/23 | 1,805 | 1,838 | 1,794 | 1,829 | +24 | +1.3% | 243,900 |
2019/07/22 | 1,806 | 1,820 | 1,799 | 1,805 | -18 | -1% | 216,700 |
2019/07/19 | 1,796 | 1,831 | 1,789 | 1,823 | +23 | +1.3% | 334,900 |
2019/07/18 | 1,842 | 1,849 | 1,796 | 1,800 | -41 | -2.2% | 271,600 |
2019/07/17 | 1,831 | 1,846 | 1,822 | 1,841 | +5 | +0.3% | 200,400 |
2019/07/16 | 1,860 | 1,866 | 1,828 | 1,836 | -32 | -1.7% | 240,100 |
2019/07/12 | 1,889 | 1,889 | 1,855 | 1,868 | -21 | -1.1% | 156,600 |
2019/07/11 | 1,866 | 1,894 | 1,856 | 1,889 | +12 | +0.6% | 141,800 |
2019/07/10 | 1,859 | 1,882 | 1,846 | 1,877 | -10 | -0.5% | 235,800 |
2019/07/09 | 1,926 | 1,926 | 1,877 | 1,887 | -23 | -1.2% | 241,300 |
2019/07/08 | 1,938 | 1,938 | 1,906 | 1,910 | -61 | -3.1% | 233,500 |
2019/07/05 | 1,998 | 1,998 | 1,959 | 1,971 | -2 | -0.1% | 205,600 |
2019/07/04 | 1,980 | 2,006 | 1,973 | 1,973 | +4 | +0.2% | 110,100 |
2019/07/03 | 1,991 | 1,999 | 1,967 | 1,969 | -21 | -1.1% | 172,600 |
2019/07/02 | 1,966 | 1,997 | 1,960 | 1,990 | +19 | +1% | 129,000 |
2019/07/01 | 1,934 | 1,974 | 1,928 | 1,971 | +63 | +3.3% | 232,900 |
2019/06/28 | 1,889 | 1,908 | 1,879 | 1,908 | +41 | +2.2% | 303,900 |
2019/06/27 | 1,859 | 1,874 | 1,855 | 1,867 | -1 | -0.1% | 161,200 |
2019/06/26 | 1,863 | 1,879 | 1,846 | 1,868 | +8 | +0.4% | 226,400 |
2019/06/25 | 1,899 | 1,904 | 1,851 | 1,860 | -19 | -1% | 278,400 |
2019/06/24 | 1,865 | 1,884 | 1,865 | 1,879 | +4 | +0.2% | 102,800 |
2019/06/21 | 1,908 | 1,908 | 1,871 | 1,875 | -39 | -2% | 249,000 |
2019/06/20 | 1,925 | 1,943 | 1,914 | 1,914 | +9 | +0.5% | 169,200 |
2019/06/19 | 1,884 | 1,908 | 1,875 | 1,905 | +46 | +2.5% | 165,600 |
2019/06/18 | 1,871 | 1,888 | 1,857 | 1,859 | -1 | -0.1% | 100,300 |
2019/06/17 | 1,880 | 1,881 | 1,860 | 1,860 | -29 | -1.5% | 90,200 |
2019/06/14 | 1,903 | 1,903 | 1,881 | 1,889 | -19 | -1% | 200,300 |
2019/06/13 | 1,915 | 1,917 | 1,894 | 1,908 | +1 | +0.1% | 182,600 |
2019/06/12 | 1,917 | 1,928 | 1,907 | 1,907 | -8 | -0.4% | 127,800 |
2019/06/11 | 1,953 | 1,953 | 1,913 | 1,915 | -53 | -2.7% | 271,100 |
2019/06/10 | 1,955 | 1,981 | 1,955 | 1,968 | +24 | +1.2% | 105,500 |
2019/06/07 | 1,955 | 1,971 | 1,935 | 1,944 | +18 | +0.9% | 166,600 |
2019/06/06 | 1,912 | 1,944 | 1,902 | 1,926 | -7 | -0.4% | 196,200 |
2019/06/05 | 1,897 | 1,943 | 1,886 | 1,933 | +67 | +3.6% | 203,700 |
2019/06/04 | 1,886 | 1,894 | 1,858 | 1,866 | +9 | +0.5% | 186,200 |
2019/06/03 | 1,872 | 1,872 | 1,849 | 1,857 | -40 | -2.1% | 144,700 |
2019/05/31 | 1,889 | 1,917 | 1,888 | 1,897 | -5 | -0.3% | 215,300 |
2019/05/30 | 1,929 | 1,935 | 1,883 | 1,902 | -46 | -2.4% | 175,400 |
2019/05/29 | 1,905 | 1,960 | 1,893 | 1,948 | +6 | +0.3% | 313,900 |
2019/05/28 | 1,956 | 1,957 | 1,931 | 1,942 | -23 | -1.2% | 287,500 |
2019/05/27 | 1,973 | 1,975 | 1,958 | 1,965 | -8 | -0.4% | 91,400 |
2019/05/24 | 1,971 | 1,986 | 1,957 | 1,973 | +17 | +0.9% | 145,400 |
2019/05/23 | 1,934 | 1,963 | 1,934 | 1,956 | +18 | +0.9% | 189,500 |
2019/05/22 | 1,960 | 1,962 | 1,920 | 1,938 | -2 | -0.1% | 235,200 |
2019/05/21 | 1,922 | 1,960 | 1,913 | 1,940 | +20 | +1% | 178,500 |
2019/05/20 | 1,944 | 1,953 | 1,911 | 1,920 | -27 | -1.4% | 131,200 |
2019/05/17 | 1,907 | 1,949 | 1,896 | 1,947 | +77 | +4.1% | 287,300 |
2019/05/16 | 1,938 | 1,941 | 1,861 | 1,870 | -64 | -3.3% | 373,300 |
2019/05/15 | 2,002 | 2,005 | 1,911 | 1,934 | -52 | -2.6% | 299,300 |
2019/05/14 | 2,000 | 2,021 | 1,950 | 1,986 | -34 | -1.7% | 344,800 |
1401~
1450
件表示中 / 3681件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 144,100円 | +3.2% | +4.5% | 3.61% | 16.56倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 226,400円 | +14.2% | +41.0% | 2.03% | 11.09倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 296,300円 | +3.0% | +27.5% | 2.70% | 18.76倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 179,000円 | +21.7% | +999.9% | 0.00% | 7.45倍 | 2.47倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 218,600円 | +0.4% | -8.4% | 2.42% | 28.06倍 | 1.59倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム